US2009270337A1PendingUtilityA1
Composition Comprising Carbohydrates and Peptides which Comprise Tryptophan
Est. expiryApr 29, 2028(~1.8 yrs left)· nominal 20-yr term from priority
Inventors:Rudolf Franciscus Van BeckhovenAlexander Lucia Leonardus DuchateauLuppo EdensFranciscus KleinherenbrinkJoris KloekAndre Leonardus De Roos
A61P 25/20A61P 25/00A61P 25/28A23L 2/52A23V 2002/00A23L 33/17A23L 27/33A23L 29/35A23L 33/18A23J 1/08A23L 29/274A23J 3/34A23L 33/125A23L 29/30A23L 27/34A23L 2/66A23L 5/00
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An edible composition comprising peptides rich in tryptophan, which edible composition further comprises a rapidly available glucose composition and a slowly available glucose composition.
Claims
exact text as granted — not AI-modified1 . A formulation comprising at least two different water-soluble, tryptophan-containing peptides, and wherein the tryptophan/LNAA ratio of the formulation is between 0.15 and 1.8, which composition further comprises a rapidly available glucose (RAG) composition and a slowly available glucose (SAG) composition, wherein the RAG composition and the SAG composition are present in the formulation in dry weight ratio's of: RAG composition: SAG composition between 1:1 and 1:3.
2 . The formulation according to claim 1 , wherein the weight ratio of the tryptophan-containing peptides: RAG composition is between 1:3 and 1:8.
3 . The formulation according to claim 1 , which comprises the peptides AW and GNW.
4 . The formulation according to claim 3 , wherein the molar ratio of AW to GNW is between 1 to 2 and 5 to 1.
5 . A formulation comprising at least two different peptides selected from di- or tripeptides, whereby two peptides selected from di- or tripeptides are each present in an amount of at least 5 mol % of the total amount of di- and tripeptides, and in which more than 30 mol % of the total tryptophan is present as peptide bound tryptophan, more than 80 mol % of the peptide-bound tryptophan is present in the form of a di- or a tripeptide, and the formulation has a tryptophan/LNAA ratio of between 0.15 and 1.8, which formulation further comprises a rapidly available glucose (RAG) composition and a slowly available glucose (SAG) composition, wherein the RAG composition and the SAG composition are present in the formulation in dry weight ratio's of: RAG composition: SAG composition between 1:1 and 1:3
6 . The formulation according to claim 5 , wherein the weight ratio of the tryptophan-containing peptides: RAG composition is between 1:3 and 1:8.
7 . The formulation according to claim 1 , wherein the tryptophan-containing peptides are obtainable by hydrolysing a hen egg lysozyme.
8 . The formulation according to claim 1 , wherein the slowly available glucose (SAG) composition comprises one or more of: pullulan having a number average molecular weight of between 1000 and 45000 daltons, isomaltulose, trehalose, or mixtures thereof.
9 . The formulation according to claim 1 , wherein the rapidly available glucose (RAG) composition comprises one or more of glucose, sucrose, maltodextrine, starch, starch hydrolysate, dextrose, or mixtures thereof.
10 . The formulation according to claim 1 , wherein it is ready for consumption and wherein the total amount of rapidly available glucose and slowly available glucose together is 5 to 20% (by weight) of the total formulation ready for consumption.
11 . The formulation according to claim 1 , wherein it comprises 0.8 to 3% of dry weight of the tryptophan-comprising peptide composition on ready to consume product.
12 . A food, pet food, feed, drink, dietary supplement or neutraceutical composition comprising the formulation according to claim 1 .
13 . A product according to claim 11 , in the form of a ready-to-drink liquid.
14 . A product according to claim 12 , which comprises 1-20% by weight of a formulation according to claim 1 .Join the waitlist — get patent alerts
Track US2009270337A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.